The following list includes contraindications of Cimzia. If you’ve had an allergic reaction. If you’ve had an allergic reaction to Cimzia or any of its ingredients, your doctor likely won’t ...
In April 2008, certolizumab pegol (Cimzia; UCB), a tumour-necrosis factor blocker, was approved by the US FDA for the treatment of adult patients with moderate-to-severe Crohn's disease who have ...
The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis, marking the company’s entry into immuno-dermatology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback